Suchergebnisse - "Koterba, Alan"

1

Patients with Rheumatologic Disorders May Develop Pain with Immunoglobulin Replacement, Requiring the Use of Daily Subcutaneous Therapy

von: Koterba, Alan

2015, in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward

Wird geladen...
2

Initiation of immunoglobulin therapy by subcutaneous administration in immunodeficiency patients naive to replacement therapy

von: Koterba, Alan P

2014, in: Allergy, asthma and clinical immunology

Wird geladen...
3

Modified Oral Rapid Drug Desensitization (ORDD) to Ibrutinib in a Patient with Stage IV Mantle Cell Lymphoma and Early Onset Grade 1 Hypersensitivity Reaction

von: Perez, Elena E.

2017, in: Antidiabetic treatment in elderly patients with low performance status admitted to internal medicine ward

Wird geladen...
4

Acetaldehyde alters coagulation protein function

von: Basista, Michael H.

1994, in: Digestive diseases and sciences

Wird geladen...
5

Subcutaneous Immunoglobulin 16.5% (Cutaquig) in Primary Immunodeficiency Disease: Safety, Efficacy, and Patient Satisfaction with Modified Dosing Regimens

von: Gupta, Sudhir

2023, in: Clinical immunology

Wird geladen...
6

Subcutaneous Immunoglobulin 16.5% (Cutaquig) is Safe and Efficacious at Modified Dosing Regimens in Patients With Primary Immunodeficiency Disease

von: Gupta, Sudhir

2022, in: The journal of allergy and clinical immunology

Wird geladen...
7

Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens

von: Gupta, Sudhir

2023, in: Journal of clinical immunology

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!